DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Scott Weiner will be moderating a panel, The Partnering Conundrum: To Partner or Not to Partner, That is the Question…, at the Bio 2011 conference in Washington, D.C.
News | 06. 28. 2011
